Esmaeili, YasamanSeyedhosseini Ghaheh, HooriaGhasemi, FahimehShariati, LalehRafienia, MohammadBidram, ElhamZarrabi, Ali2022-07-202022-07-202022Esmaeili, Y., Seyedhosseini Ghaheh, H., Ghasemi, F., Shariati, L., Rafienia, M., Bidram, E., & Zarrabi, A. (2022). Graphene oxide quantum dot-chitosan nanotheranostic platform as a pH-responsive carrier for improving curcumin uptake internalization: In vitro & in silico study. Biomaterials Advances, 139 doi:10.1016/j.bioadv.2022.2130172772-9508https://doi.org/10.1016/j.bioadv.2022.213017https://hdl.handle.net/20.500.12713/3025We herein fabricated a cancer nanotheranostics platform based on Graphene Oxide Quantum Dot-Chitosan-polyethylene glycol nanoconjugate (GOQD-CS-PEG), which were targeted with MUC-1 aptamer towards breast and colon tumors. The interaction between aptamer and MUC-1 receptor on the desired cells was investigated utilizing molecular docking. The process of curcumin release was investigated, as well as the potential of the produced nanocomposite in targeted drug delivery, specific detection, and photoluminescence imaging. The fluorescence intensity of GOQD-CS-PEG was reduced due to transferred energy between (cytosine-guanin) base pairs in the hairpin structure of the aptamer, resulting in an “on/off” photoluminescence bio-sensing. Interestingly, the integration of pH-responsive chitosan nanoparticles in the nanocomposite results in a smart nanocomposite capable of delivering more curcumin to desired tumor cells. When selectively binds to the MUC-1 receptor, the two strands of aptamer separate in acidic conditions, resulting in a sustained drug release and photoluminescence recovery. The cytotoxicity results also revealed that the nanocomposite was more toxic to MUC-1-overexpressed tumor cells than to negative control cell lines, confirming its selective targeting. As a result, the proposed nanocomposite could be used as an intelligent cancer nanotheranostic platform for tracing MUC-1-overexpressed tumor cells and targeting them with great efficiency and selectivity. © 2022 Elsevier B.V.eninfo:eu-repo/semantics/closedAccessAnticancer NanotheranosticsCurcumin DeliveryGraphene Oxide Quantum DotsIn SilicoTargeted Therapy“On/off” Photoluminescence Bio-SensingArticle139WOS:0008340764000012-s2.0-85133883776N/A10.1016/j.bioadv.2022.213017N/A